Infants born prematurely are known to display longstanding bronchial hyperreactivity. The mechanism responsible for this is still unclear. Eosinophils are thought to play a central part in the development of bronchial hyperreactivity in asthma. It was the aim of this study to assess the relation of bronchial hyperresponsiveness to potential markers of eosinophilic inflammation in peripheral blood.
Abstract
Infants born prematurely are known to display longstanding bronchial hyperreactivity. The mechanism responsible for this is still unclear. Eosinophils are thought to play a central part in the development of bronchial hyperreactivity in asthma. It was the aim of this study to assess the relation of bronchial hyperresponsiveness to potential markers of eosinophilic inflammation in peripheral blood.
Eosinophil count, the concentration of serum eosinophilic cationic protein, the capacity of purified eosinophils to generate leukotriene C4, and bronchial reactivity was studied in 24 non-atopic children born prematurely, 12 healthy controls, and 12 children with asthma aged 6 to 9 years. There was no difference in serum concentrations on eosinophil cationic protein and eosinophil counts. However, eosinophils from the 15 formerly preterm infants with significant bronchial hyperreactivity generated significantly higher amounts of leukotriene C4 than normal controls and prematurely born children without bronchial hyperreactivity. Levels of leukotriene C4 in this group were comparable with those obtained with eosinophils from patients with asthma. In contrast with cells from the other groups, eosinophils from the children with bronchial hyperreactivity born prematurely show no enhancement of leukotriene C4 generation on prestimulation with platelet activating factor.
It is concluded that bronchial hyperreactivity of children born prematurely is accompanied by the This study considered whether there is a relation between the activity of eosinophils isolated from peripheral blood and bronchial hyperreactivity in formerly premature children. We studied 24 formerly premature children, 12 healthy age matched controls, and 12 children with asthma.
Methods

PATIENTS
Formerly premature children Twenty four children who had been admitted to the neonatal intensive care unit during the period between 1983 and 1985 and who had a documented delivery at the 30th to 36th week of gestation were studied. All children were non-atopic as defined by negative skin prick test and normal IgE. Fifteen children showed bronchial hyperreactivity (determined as the concentration of inhaled histamine that caused a decrease of 60% in the specific conductance (PC60sGaw) <6-0 mg/ml histamine), whereas nine children showed normal bronchial reactivity (PC60sGaw >6 0 mg/ml histamine) ( 
Controls
Twelve volunteers aged 6-9 years with no previous history of asthma, skin disease, or other allergy related diseases, and normal deliveries were examined. The children had negative personal and family histories of atopy and a normal concentration of total serum IgE. In addition, no specific IgE to inhaled allergens could be detected by skin prick test (table 1) .
Patients with asthma Twelve children (age 6-9 years) were studied in whom asthma has been diagnosed on the basis of a history of episodic wheezing and impaired lung function tests. These patients were free of lesions from atopic dermatitis (table 1) .
INFORMED CONSENT
The study was approved by the ethical committee of the Philipps University. Parents and children gave informed consent.
CLINICAL EVALUATION
Assessment of all patients entering the study was performed in the afternoon to avoid circadian variations in bronchial hyperreactivity and eosinophil functions. In the group with asthma, drugs were withheld for at least 12 hours before venous puncture and pulmonary function testing. The patients and their parents were asked about the severity of respiratory symptoms and the patients underwent a detailed physical examination and a skin test with extracts of nine common allergens (Dermatophagoides pteronyssinus, timothy, birch, mugwort, cat, dog, altemaria, cladosporium, aspergillus). A weal of >2 mm was considered as positive. Age at onset of asthmatic symptoms and atopic dermatitis, drugs taken, and number of positive skin tests were recorded. Blood was drawn for the determination of serum IgE and eosinophil function, and pulmonary function tests including histamine challenge were performed.
In addition, the parents completed a questionnaire about socioeconomic status, number of siblings, pets, parental smoking, home cooking with gas stove, and the frequency of wheeze and cough in the last tliree months.
SERUM IgE
Serum IgE of each child was detected using a commercial ELISA kit (Behringwerke).
PULMONARY FUNCTION TEST
A maximum flow expiratory volume curve was recorded to determine the volume expired at the first second of the forced expiration (FEVI) and the maximum expiratory flow at 25% of remaining vital capacity (MEF25). For this measurements mouth flow was integrated to obtain volume. The values of FEV1 and MEF25 are given as percentages of the predicted value according to height and weight of the patient.
The degree of bronchial hyperreactivity was determined by unspecific provocation testing with inhaled histamine using a modified version of the protocol described by Cockcroft et al.9 Histamine dehydrochloride in buffered saline was nebulised in a 10 litre reservoir by pressure nebuliser (Pari Provotest, particle size 0 5-5 pum) with increasing concentrations (O 5, 1, 2, 4, and 8 mg/ml). To fill the reservoir, 0 75 ml histamine solution and 120 seconds of nebulisation were necessary. When the reservoir was full, the nebulised aerosol was inhaled by tidal inhalation through a one way valve. One minute after inhalation the thoracic gas volume (TGV) and airway resistance (Raw) were measured in a pressure corrected flow plethysmograph with the patient in the sitting position. The specific conductance (sGaw) was calculated from the reciprocal Raw/TGV. Bronchial hyperreactivity was determined as the concentration of inhaled histamine that caused a decrease of 60% in the specific conductance (PC60sGaw).
Duplicate reactivity tests within one week displayed a difference between two measurements within 1 1 doubling steps of histamine. the cells (2X 106/ml) were layered onto a discontinuous isotonic Percoll (Pharmacia) gradient with densities of 1 070 and 1 085 g/ml and centrifuged for 30 minutes (1200 g, 25°C). The eosinophilic leucocytes at the bottom of the tubes were resuspended in washing buffer, counted, assessed for their purity, and, if the purity was lower than 75°/0, layered onto a second discontinuous isotonic Percoll gradient with densities of 1-095, 1-105 g/ml in the ratio 1:0-5 respectively. The cells were separated by centrifugation for 20 minutes (1200 g, 250C). The recovery of eosinophils collected from the fraction 1-105 g/ml Percoll was >900/o in all subjects studied. Incubations were performed with or without ionophore A 23187 (0-2 ,ug/ml) for 30 minutes at 37°C. Catalase (Sigma) at a concentration of 3000 U/ml was included in all incubations. In some experiments, a parallel culture was set up after preincubation with platelet activating factor (Sigma) at a concentration of 0-12 ,umol for 10 minutes at 37°C. Platelet activating factor itself did not induce leukotriene C4 generation in the absence of the ionophore A 23187. At the end of incubation, the test tubes were centrifuged and the supernatants were collected and analysed for leukotrienes.
QUANTITATION OF LEUKOTRIENES
The radioimmunoassayl1 for leukotriene C4 was performed in 300 [lI volumes that contained TRIS Isogel buffer (0-1 M TRISHCl, 0-14 M NaCl, 1-5 mM CaCl2+, 5 mM MgCl2+, pH 7 4), culture supernatant or synthetic leukotriene C4 labelled with tritium (specific activity 34 Ci/mmol; New England Nuclear) and a rabbit antiserum to leukotriene C4 (also specific for leukotriene D4 and leukotriene E4) in 1-5 ml polypropylene test tubes. One hundred microlitres of goat antirabbit IgG serum were added at slight antibody excess and incubation was continued for 18 hours at 4°C. The immune precipitate was sedimented by centrifugation at 2500 g for 25 minutes at 4°C dissolved in 500 pd of 0'1 M NaOH, mixed with 4 ml Readysolve (Beckman), and assessed for radioactivity in a liquid scintillation counter. A calibration graph was established with synthetic leukotriene C4 in the range 0 4-10 ng. The data are expressed as the mean of duplicate samples. The method has been shown to be suitable for the detection of leukotriene C4 in supernatants of ionophore A 23187 stimulated cells. 
Results
Eosinophils isolated from the peripheral blood of 15 prematurely born children with bronchial hyperresponsiveness (PC60sGaw <6-0 mg/ml histamine), nine prematurely born children with normal bronchial hyperresponsiveness (PC60sGaw >6-0 mg/ml histamine), 12 children with asthma, and 12 healthy children were compared for their ability to produce leukotriene C4 after a challenge with ionophore A 23187 in vitro. Figure 1 shows that eosinophils isolated from the peripheral blood of prematurely born children with bronchial hyperresponsiveness produced significantly more leukotriene C4 than hypodense eosinophils from prematurely born children without bronchial hyperresponsiveness or healthy children. In this regard the hyperreactive group was comparable with patients with asthma. When eosinophils were preincubated with platelet activating factor at a concentration which in itself does not induce leukotriene C4 generation, however, cells from all other groups but not from the hyperreactive formerly premature group showed an enhancement of ionophore induced leukotriene C4 generation (fig 2) . There was no difference in eosinophil number or the concentration of IgE eosinophilic cationic protein (table 1) .
To assess whether the activity of isolated eosinophils is the only difference between hyperreactive and normoreactive formerly premature children we analysed a number of confounding factors known to influence bronchial hyperreactivity in childhood. There was no difference in gestational age, age at follow up, or atopic status. The hyperreactive group had a lower birth weight, but the difference did not reach statistical significance (p=026) ( (table 4) .
Discussion
In this study we show that eosinophils from prematurely born children with bronchial hyperreactivity generate significantly more leukotriene C4 than eosinophils from normal control children or from prematurely born children with normal bronchial reactivity. In this regard eosinophils from the hyperreactive group behave like eosinophils isolated from the peripheral blood of children with asthma.
As other risk factors for the development of bronchial hyperreactivity'3 are evenly distributed between the hyperreactive and the increased in the prematurely born children, it seems that not haematopoietic but chemotactic factors are responsible for the observed in vivo prestimulation of eosinophils. Furthermore, the lack of haematopoietic factors might be responsible for the lack of symptoms found in our patients. In vivo20 and in vitro2l studies show that marked eosinophil chemotaxis and hence eosinophilic inflammation is induced only when haematopoietic and chemotactic factors are present. A candidate for a chemotactic factor is platelet activating factor, which has been shown to induce bronchial hyperreactivity on inhalation.22 In addition, platelet activating factor has been implicated in the pathophysiology of bronchopulmonary dysplasia23 as well as premature labour.24 This is interesting because Nickerson and Taussig has postulated a common genetic defect leading to bronchial hyperreactivity, bronchopulmonary dysplasia, and premature labour. 5 These considerations are highly speculative, however, and are beyond the scope of the present report. Nevertheless, the presented work might be the basis of further research to clarify the association between eosinophil stimulation, bronchial hyperreactivity, and premature birth.
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